Sign in →

Epic Code LAB848 68kD (hsp-70) antibodies by Line Blot

Important Note

Order as Reference Miscellaneous #LAB848; indicate complete test name when ordering.

Additional Codes

Mayo Code: F68KD

Performing Laboratory

IMMCO Diagnostics, Inc.

Specimen Type

Serum


Specimen Required


Draw blood in a plain red-top tube(s), serum gel tube(s) is acceptable. Spin down and send 3 mL of serum frozen in a plastic vial.


Laboratory Test Directory Note:

COLLECTION NOTE: Volumes listed are in serum or plasma, draw approximately 2 1/2 times the requested volume in whole blood.

Specimen Minimum Volume

2.0 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Frozen (preferred) 365 days
  Refrigerated  5 days
  Ambient  48 hours

Day(s) Performed

Once per week

Reference Values

Qualitative test - Positive or Negative

Interpretation

Antibodies to inner ear antigen (68kDa) occur in approximately 70% of patients with autoimmune hearing loss. The antibody tests to this 68kDa antigen parallel with disease activity. In addition, a majority of patients positive for antibodies to 68kDa are responsive to corticosteroid treatment.(Hirose et al. The Laryngoscope. 109:1769-1999)

Reporting Name

68kD (hsp-70) antibodies

Method Name

Line Immunoassay

CPT Code Information

84182

LOINC Code Information

Test ID Test Order Name Order LOINC Value
F68KD 68kD (hsp-70) antibodies 43597-4

 

Result ID Test Result Name Result LOINC Value
Z0909 68kD (hsp-70) antibodies 43597-4

Report Available

3 to 18 days

Test Classification

This test has been developed and performance parameters have been validated by IMMCO Diagnostics, Inc. This test has not been approved by the U.S. Food and Drug Administration (FDA); however, US FDA approval is not required for clinical use. It is not intended that clinical diagnosis and patient management decisions be made using these results alone. This test has been validated using serum samples. The manufacturer has not determined the efficacy of this test when performed on CSF, plasma, joint or pleural fluid specimens. The performance characteristics of this test were determined by IMMCO Diagnostics Inc.